Table 6 Treatment outcome of TB patients in the clinical trial, during two years prior to the clinical trial, and during the two years following the clinical trial
Treatment outcome | Year | |||||
|---|---|---|---|---|---|---|
2012a n (%) | 2013a n (%) | 2014, intervention n (%) | 2014, control n (%) | 2015a n (%) | 2016a n (%) | |
Success | 511 (82.4%) | 513 (86.2%) | 206 (90.8%) | 195 (93.3%) | 421 (81.9%) | 310 (81.8%) |
Lost to follow-up | 78 (12.6%) | 53 (8.9%) | 16 (7.0%) | 10 (4.8%) | 65 (12.6%) | 46 (12.1%) |
Failure | 6 (1.0%) | 9 (1.5%) | 1 (0.4%) | 0 (0.0%) | 7 (1.4%) | 6 (1.6%) |
Death | 22 (3.5%) | 16 (2.7%) | 3 (1.3%) | 3 (1.4%) | 21 (4.1%) | 9 (2.4%) |
Not evaluated | 3 (0.5%) | 4 (0.7%) | 1 (0.4%) | 1 (0.5%) | 0 (0.0%) | 8 (2.1%) |